The interaction between peripheral blood CD34 and CD3 chimerism (Figure 5) showed that the 95% threshold of CD34 chimerism values far outweighs the effect of changes in CD3 chimerism in ALL and vice versa in AML. The gene discussed is CD34; the disease is acute lymphoblastic leukemia.